|
1
|
Ali FEA, Barnham KJ, Barrow CJ and
Separovic F: Metal-catalyzed oxidative damage and oligomerization
of the amyloid-peptide of Alzheimer's disease. Aust J Chem.
57:511–518. 2004. View
Article : Google Scholar
|
|
2
|
Baldeiras I, Santana I, Proença MT,
Garrucho MH, Pascoal R, Rodrigues A, Duro D and Oliveira CR:
Oxidative damage and progression to Alzheimer's disease in patients
with mild cognitive impairment. J Alzheimers Dis. 21:1165–1177.
2010.PubMed/NCBI
|
|
3
|
Zhang F and Jiang L: Neuroinflammation in
Alzheimer's disease. Neuropsychiatr Dis Treat. 11:243–256. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Birch AM, Katsouri L and Sastre M:
Modulation of inflammation in transgenic models of Alzheimer's
disease. J Neuroinflammation. 11:252014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Finch CE and Morgan TE: Systemic
inflammation, infection, ApoE alleles, and Alzheimer disease: a
position paper. Curr Alzheimer Res. 4:185–189. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frank B and Gupta S: A review of
antioxidants and Alzheimer's disease. Ann Clin Psychiatry.
17:269–286. 2005. View Article : Google Scholar
|
|
7
|
Zhu X, Su B, Wang X, Smith MA and Perry G:
Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci.
64:2202–2210. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Heneka MT and O'Banion MK: Inflammatory
processes in Alzheimer's disease. J Neuroimmunol. 184:69–91. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
El Khoury J and Luster AD: Mechanisms of
microglia accumulation in Alzheimer's disease: therapeutic
implications. Trends Pharmacol Sci. 29:626–632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mandrekar-Colucci S, Karlo JC and Landreth
GE: Mechanisms underlying the rapid peroxisome
proliferator-activated receptor-γ-mediated amyloid clearance and
reversal of cognitive deficits in a murine model of Alzheimer's
disease. J Neurosci. 32:10117–10128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Noble W, Garwood C, Stephenson J, Kinsey
AM, Hanger DP and Anderton BH: Minocycline reduces the development
of abnormal tau species in models of Alzheimer's disease. FASEB J.
23:739–750. 2009. View Article : Google Scholar
|
|
12
|
Sastre M and Gentleman SM: NSAIDs: how
they work and their prospects as therapeutics in Alzheimer's
disease. Front Aging Neurosci. 2:202010.PubMed/NCBI
|
|
13
|
Seabrook TJ, Jiang L, Maier M and Lemere
CA: Minocycline affects microglia activation, Abeta deposition, and
behavior in APP-tg mice. Glia. 53:776–782. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tweedie D, Ferguson RA, Fishman K,
Frankola KA, Van Praag H, Holloway HW, Luo W, Li Y, Caracciolo L,
Russo I, et al: Tumor necrosis factor-α synthesis inhibitor
3,6′-dithiothalidomide attenuates markers of inflammation,
Alzheimer pathology and behavioral deficits in animal models of
neuroinflammation and Alzheimer's disease. J Neuroinflammation.
9:1062012. View Article : Google Scholar
|
|
15
|
Chan MM, Huang HI, Fenton MR and Fong D:
In vivo inhibition of nitric oxide synthase gene expression by
curcumin, a cancer preventive natural product with
anti-inflammatory properties. Biochem Pharmacol. 55:1955–1962.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Ho L, Zhao W, Ono K, Rosensweig C,
Chen L, Humala N, Teplow DB and Pasinetti GM: Grape-derived
polyphenolics prevent Abeta oligomerization and attenuate cognitive
deterioration in a mouse model of Alzheimer's disease. J Neurosci.
28:6388–6392. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia EQ, Deng GF, Guo YJ and Li HB:
Biological activities of polyphenols from grapes. Int J Mol Sci.
11:622–646. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang F, Lim GP, Begum AN, Ubeda OJ,
Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA
and Cole GM: Curcumin inhibits formation of amyloid beta oligomers
and fibrils, binds plaques, and reduces amyloid in vivo. J Biol
Chem. 280:5892–5901. 2005. View Article : Google Scholar
|
|
19
|
Jeong KY, Han IS, Choi SY, Lee JH, Lee JS,
Hong CS and Park JW: Allergenicity of recombinant profilins from
Japanese hop, Humulus japonicus. J Investig Allergol Clin Immunol.
23:345–350. 2013.PubMed/NCBI
|
|
20
|
Lee YR, Kim KY, Lee SH, Kim MY, Park HJ
and Jeong HS: Antioxidant and antitumor activities of methanolic
extracts from Humulus japonicus. Korean J Food Nutr. 25:357–361.
2012. View Article : Google Scholar
|
|
21
|
Park SW, Woo CJ, Chung SK and Chung KT:
Antimicrobial and antioxidative activities of solvent fraction from
Humulus japonicus. Korean J Food Sci Technol. 26:464–470. 1994.
|
|
22
|
Hwang SY, Jo MJ, Kim SC and Jee SY:
Anti-inflammaory effects of the MeOH extract of Humulus japonicus
in vivo. J Korean Orient Med Ophthalmol Otolaryngol Derm.
22:92–103. 2009.
|
|
23
|
Jankowsky JL, Fadale DJ, Anderson J, Xu
GM, Gonzales V, Jenkins NA, Copeland NG, Lee MK, Younkin LH, Wagner
SL, et al: Mutant presenilins specifically elevate the levels of
the 42 residue beta-amyloid peptide in vivo: evidence for
augmentation of a 42-specific gamma secretase. Hum Mol Genet.
13:159–170. 2004. View Article : Google Scholar
|
|
24
|
Jankowsky JL, Slunt HH, Ratovitski T,
Jenkins NA, Copeland NG and Borchelt DR: Co-expression of multiple
transgenes in mouse CNS: a comparison of strategies. Biomol Eng.
17:157–165. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Park HY, Kang YM, Kang Y, Park TS, Ryu YK,
Hwang JH, Kim YH, Chung BH, Nam KH, Kim MR, et al: Inhibition of
adenylyl cyclase type 5 prevents L-DOPA-induced dyskinesia in an
animal model of Parkinson's disease. J Neurosci. 34:11744–11753.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Akkerman S, Blokland A, Reneerkens O, van
Goethem NP, Bollen E, Gijselaers HJ, Lieben CK, Steinbusch HW and
Prickaerts J: Object recognition testing: methodological
considerations on exploration and discrimination measures. Behav
Brain Res. 232:335–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Antunes M and Biala G: The novel object
recognition memory: neurobiology, test procedure, and its
modifications. Cogn Process. 13:93–110. 2012. View Article : Google Scholar :
|
|
28
|
Wasilewska-Sampaio AP, Santos TG, Lopes
MH, Cammarota M and Martins VR: The growth of glioblastoma
orthotopic xenografts in nude mice is directly correlated with
impaired object recognition memory. Physiol Behav. 123:55–61. 2014.
View Article : Google Scholar
|
|
29
|
Belforte JE, Zsiros V, Sklar ER, Jiang Z,
Yu G, Li Y, Quinlan EM and Nakazawa K: Postnatal NMDA receptor
ablation in cortico-limbic interneurons confers schizophrenia-like
phenotypes. Nat Neurosci. 13:76–83. 2010. View Article : Google Scholar
|
|
30
|
Kim KS, Kang YM, Kang Y, Park TS, Park HY,
Kim YJ, Han BS, Kim CH, Lee CH, Ardayfio PA, et al: Pitx3 deficient
mice as a genetic animal model of co-morbid depressive disorder and
parkinsonism. Brain Res. 1552:72–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sierksma AS, Prickaerts J, Chouliaras L,
Rostamian S, Delbroek L, Rutten BP, Steinbusch HW and van den Hove
DL: Behavioral and neurobiological effects of prenatal stress
exposure in male and female APPswe/PS1dE9 mice. Neurobiol Aging.
34:319–337. 2013. View Article : Google Scholar
|
|
32
|
Hafez D, Huang JY, Huynh AM, Valtierra S,
Rockenstein E, Bruno AM, Lu B, DesGroseillers L, Masliah E and Marr
RA: Neprilysin-2 is an important β-amyloid degrading enzyme. Am J
Pathol. 178:306–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang
J, Podlisny MB, Rosner MR, Safavi A, Hersh LB and Selkoe DJ:
Insulin-degrading enzyme regulates extracellular levels of amyloid
beta-protein by degradation. J Biol Chem. 273:32730–32738. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sastre M, Klockgether T and Heneka MT:
Contribution of inflammatory processes to Alzheimer's disease:
molecular mechanisms. Int J Dev Neurosci. 24:167–176. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McGeer PL and McGeer EG: The inflammatory
response system of brain: implications for therapy of Alzheimer and
other neurodegenerative diseases. Brain Res Brain Res Rev.
21:195–218. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rubio-Perez JM: A review: inflammatory
process in Alzheimer's disease, role of cytokines. ScientificWord
Journal. 2012:7563572012.
|
|
37
|
Town T, Nikolic V and Tan J: The
microglial 'activation' continuum: from innate to adaptive
responses. J Neuroinflammation. 2:242005. View Article : Google Scholar
|
|
38
|
Brown GC and Bal-Price A: Inflammatory
neurodegeneration mediated by nitric oxide, glutamate, and
mitochondria. Mol Neurobiol. 27:325–355. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Halliday G, Robinson SR, Shepherd C and
Kril J: Alzheimer's disease and inflammation: a review of cellular
and therapeutic mechanisms. Clin Exp Pharmacol Physiol. 27:1–8.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jo S, Yarishkin O, Hwang YJ, Chun YE, Park
M, Woo DH, Bae JY, Kim T, Lee J, Chun H, et al: GABA from reactive
astrocytes impairs memory in mouse models of Alzheimer's disease.
Nat Med. 20:886–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Akiyama H, Barger S, Barnum S, Bradt B,
Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich
BL, et al: Inflammation and Alzheimer's disease. Neurobiol Aging.
21:383–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo HB, Cheng YF, Wu JG, Wang CM, Wang HT,
Zhang C, Qiu ZK and Xu JP: Donepezil improves learning and memory
deficits in APP/PS1 mice by inhibition of microglial activation.
Neuroscience. 290:530–542. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Edbauer D, Winkler E, Regula JT, Pesold B,
Steiner H and Haass C: Reconstitution of gamma-secretase activity.
Nat Cell Biol. 5:486–488. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vassar R, Bennett BD, Babu-Khan S, Kahn S,
Mendiaz EA, Denis P, Teplow DB, Ross S, Amarante P, Loeloff R, et
al: Beta-secretase cleavage of Alzheimer's amyloid precursor
protein by the transmembrane aspartic protease BACE. Science.
286:735–741. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Iwata N, Tsubuki S, Takaki Y, Watanabe K,
Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E,
Sekine-Aizawa Y and Saido TC: Identification of the major
Abeta1-42-degrading catabolic pathway in brain parenchyma:
suppression leads to biochemical and pathological deposition. Nat
Med. 6:143–150. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
46
|
Leissring MA, Farris W, Chang AY, Walsh
DM, Wu X, Sun X, Frosch MP and Selkoe DJ: Enhanced proteolysis of
beta-amyloid in APP transgenic mice prevents plaque formation,
secondary pathology, and premature death. Neuron. 40:1087–1093.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vekrellis K, Ye Z, Qiu WQ, Walsh D,
Hartley D, Chesneau V, Rosner MR and Selkoe DJ: Neurons regulate
extracellular levels of amyloid beta-protein via proteolysis by
insulin-degrading enzyme. J Neurosci. 20:1657–1665. 2000.PubMed/NCBI
|
|
48
|
Leal MC, Dorfman VB, Gamba AF, Frangione
B, Wisniewski T, Castaño EM, Sigurdsson EM and Morelli L:
Plaque-associated overexpression of insulin-degrading enzyme in the
cerebral cortex of aged transgenic tg2576 mice with Alzheimer
pathology. J Neuropathol Exp Neurol. 65:976–987. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cook DG, Leverenz JB, McMillan PJ, Kulstad
JJ, Ericksen S, Roth RA, Schellenberg GD, Jin LW, Kovacina KS and
Craft S: Reduced hippocampal insulin-degrading enzyme in late-onset
Alzheimer's disease is associated with the apolipoprotein
E-epsilon4 allele. Am J Pathol. 162:313–319. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hong MS, Son ES, Lee SJ, Lee SK, Lee YJ,
Song SD, Cho SN, Barry CE III and Eum SY: Anti-mycobacterial
Effects of the Extract of Humulus japonicas. Korean J Food Sci
Technol. 46:94–99. 2014. View Article : Google Scholar
|
|
51
|
Park SW, Kim SH and Chung SK:
Antimutagenic effects and isolation of flavonoids from HJ extract.
Korean J Food Sci Technol. 27:897–901. 1995.
|
|
52
|
Di Bona D, Scapagnini G, Candore G,
Castiglia L, Colonna-Romano G, Duro G, Nuzzo D, Iemolo F, Lio D,
Pellicanò M, et al: Immune-inflammatory responses and oxidative
stress in Alzheimer's disease: therapeutic implications. Curr Pharm
Des. 16:684–691. 2010. View Article : Google Scholar : PubMed/NCBI
|
